-
Innovative Cannabis-Derived Epilepsy Treatment Reaches UK Patients
Wednesday, May 31, 2023 - 6:36pm | 347A leading European pharmaceutical firm specializing in plant-derived medications, MGC Pharmaceuticals Ltd. (LSE: MXC), (ASX: MXC), (OTC: MGCLF) has successfully imported and delivered its ground-breaking Investigational Medicinal Product (IMP), CannEpil, to its first patients in the United Kingdom...